Debt-to-equity of BIOCEPT INC from 30 Sep 2014 to 30 Jun 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BIOCEPT INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 30 Jun 2023.
  • BIOCEPT INC Debt-to-equity for the quarter ending 30 Jun 2023 was 296%, a 333% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

BIOCEPT INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2023 296% +228% +333% 30 Jun 2023
Q1 2023 161% +96% +150% 31 Mar 2023
Q4 2022 105% +37% +53% 31 Dec 2022
Q3 2022 81% +3.7% +4.8% 30 Sep 2022
Q2 2022 68% -11% -14% 30 Jun 2022
Q1 2022 64% -2.6% -4% 31 Mar 2022
Q4 2021 68% +16% +30% 31 Dec 2021
Q3 2021 77% +38% +96% 30 Sep 2021
Q2 2021 79% +39% +96% 30 Jun 2021
Q1 2021 67% +17% +35% 31 Mar 2021
Q4 2020 52% -8.5% -14% 31 Dec 2020
Q3 2020 39% -33% -45% 30 Sep 2020
Q2 2020 40% -26% -39% 30 Jun 2020
Q1 2020 50% -38% -43% 31 Mar 2020
Q4 2019 61% -40% -40% 31 Dec 2019
Q3 2019 72% -40% -36% 30 Sep 2019
Q2 2019 67% -87% -57% 30 Jun 2019
Q1 2019 88% -39% -31% 31 Mar 2019
Q4 2018 101% -20% -16% 31 Dec 2018
Q3 2018 111% -17% -13% 30 Sep 2018
Q2 2018 154% -59% -28% 30 Jun 2018
Q1 2018 126% -349% -73% 31 Mar 2018
Q4 2017 121% +720% 31 Dec 2017
Q3 2017 128% +1750% 30 Sep 2017
Q2 2017 213% -76% -26% 30 Jun 2017
Q1 2017 475% +340% +251% 31 Mar 2017
Q4 2016 -598% -680% -834% 31 Dec 2016
Q3 2016 -1621% -1712% -1874% 30 Sep 2016
Q2 2016 290% +189% +188% 30 Jun 2016
Q1 2016 135% +20% +18% 31 Mar 2016
Q4 2015 82% -31% -28% 31 Dec 2015
Q3 2015 91% -315% -77% 30 Sep 2015
Q2 2015 101% 30 Jun 2015
Q1 2015 115% 31 Mar 2015
Q4 2014 112% 31 Dec 2014
Q3 2014 406% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.